Alembic Pharmaceuticals Ltd receives 2 observations for Karakhadi Injectable Facility

The United States Food and Drug Administration (USFDA) conducted an unannounced cGMP inspection at its Injectable Facility (F-3) located at Karakhadi from 9th February, 2026 to 18th February, 2026.

The inspection has been completed with two observations. None of the observations are related to data integrity.

The Company will respond to the observations within the stipulated time.

The Company continues to remain committed to highest quality standards and compliance.

Shares of Alembic Pharmaceuticals Limited was last trading in BSE at Rs. 776.25 as compared to the previous close of Rs. 776.40. The total number of shares traded during the day was 904 in over 163 trades.

The stock hit an intraday high of Rs. 787.25 and intraday low of 765.75. The net turnover during the day was Rs. 701745.00.

Source : Equity Bulls

Keywords

AlembicPharmaceuticals INE901L01018 Inspection USFDA Karakhadi InjectableFacility TwoObservations